Cagrilintide

Synonyms: Cagrilintide, 1415456-99-3, Amylin analog, Long-acting amylin analog, NN-9935, Cagrilintide acetate

Cagrilintide is a synthetic analog of human amylin, a peptide hormone that works alongside insulin to regulate postprandial glucose levels and signal satiety. Developed by Novo Nordisk, this long-acting amylin analog is designed for once-weekly dosing, making it a promising candidate for obesity and type 2 diabetes management. Its extended half-life is achieved through fatty acid acylation, which promotes albumin binding and slows renal clearance.

Функция

• Amylin receptor agonist: Activates amylin receptors, reducing food intake and delaying gastric emptying.
• Appetite regulation: Enhances satiety signaling, leading to reduced caloric intake.
• Контроль веса: Promotes weight loss in overweight and obese individuals.
• Glycemic control: Helps regulate postprandial glucose levels.

Источник и стандартизация

• Источник: Synthetic peptide, produced via solid-phase peptide synthesis.
• Стандартизация: Purity ≥98% (HPLC), peptide content 70-90%.
• Формы: Lyophilized powder, acetate salt.
• Приложения: Research on obesity, type 2 diabetes, and metabolic disorders.

Документация и поставки

• Минимальный объем заказа: 5 г
• Ежемесячная производственная мощность: 1 kg
• Срок выполнения заказа: 5-10 days after order
• Документация: сертификат соответствия (COA), паспорт безопасности материала (MSDS), техническое описание продукта (TDS)
• Упаковка: Sealed vials or custom packaging

Запрос Цитировать

• Наш адрес: 280 Main Street, Сиань, провинция Шэньси, Китай
• LyvBio Co., Ltd. — Электронная почта: info@lyvbio.com